Skip to main content
. 2014 Jul 17;9(7):e102641. doi: 10.1371/journal.pone.0102641

Figure 4. Dy105 treatment decreases lysenin-mediated cell mortality.

Figure 4

Huh7 cells (A) and bone marrow derived macrophages (B) were treated with Dy105 for 17 h. Medium was removed. Lysenin (200 ng/ml) in PBS was added to the cells and cell mortality was monitored by MTT. Values are mean ± SD, n = 3, *p<0.05.